Question special
Lead Moderator

We understand from previous Zika outbreaks that high Zika IgG seroprevalence in a population is usually followed by a decrease in new infections, and a "dying out" of the epidemic. In addition, several vaccine candidates appear to lead to protective immunity in mice and non-human primates. Many patients now ask, "I had a confirmed Zika virus infection in the past. Can I now travel to an area with ongoing Zika transmission without concern for re-infection?" How would you advise these patients?